TARA Q2 2023 Earnings — Protara Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena

TARAProtara Therapeutics, Inc.

$228M

Q2 2023 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

$0

Operating Income

-$12M

Net Income

-$11M

EPS (Diluted)

$-1.00

QoQ Revenue Growth

NaN%

Cash Flow

Operating Cash Flow

-$9M

Free Cash Flow

-$9M

Stock-Based Comp.

$0

Balance Sheet

Total Assets

$95M

Total Liabilities

$10M

Stockholders' Equity

$85M

Cash & Equivalents

$34M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	$0	$0	—
Operating Income	-$12M	-$9M	-39.5%
Net Income	-$11M	-$9M	-32.3%